company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2009.0,Q3,2009-07-01,2009-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,46406000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,46406000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,34000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,517000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-207000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-17319000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,29431000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,29431000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,3269000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,15000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2009.0,Q3,2009-07-01,2009-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,18269000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,18269000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,53043000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,981000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-53739000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,285000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,285000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2009.0,Q3,2009-07-01,2009-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,47985000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2009.0,Q4,2009-10-01,2009-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,28560000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,28560000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,34000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,501000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1178000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,23877000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,54150000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,54150000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-67507000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-259341000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,285746000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-1237000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,68998000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,26659000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,26659000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2009.0,Q4,2009-10-01,2009-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,80809000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2009.0,Q4,2009-10-01,2009-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,11552000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2009.0,Q4,2009-10-01,2009-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,29258000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 14:35:42+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,26007000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 14:35:42+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,26007000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 14:35:42+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,34000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 14:35:42+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2382000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 14:35:42+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-40000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 14:35:42+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1447000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 14:35:42+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,26936000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 14:35:42+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,26936000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 14:35:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 14:35:42+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 14:35:42+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 14:35:42+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-12621000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 14:35:42+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-85000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 14:35:42+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2217000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 14:35:42+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-10489000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 14:35:42+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-10489000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 14:35:42+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,16447000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,2010-04-01,2010-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-102152000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-102152000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,-105000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-7034000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-16356000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-24916000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-150563000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-150563000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-12402000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,2010-04-01,2010-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-12402000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-12402000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-138130000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-59779000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5258000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-192651000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-192651000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,247254000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,2010-04-01,2010-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-108362000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,192479000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,192479000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,256000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,11429000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,35312000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,38464000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,277940000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,277940000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-16408000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-14408000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-14408000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-29931000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2827000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-27104000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-27104000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-247254000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10826000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,2010-07-01,2010-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,34440000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,2010-07-01,2010-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,48000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24460000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24460000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,145000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-5095000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,71526000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-12129000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,29987000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,29987000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-17858000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7772000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10086000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10086000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-23295000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-70179000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,82039000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2622000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-8813000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-8813000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,11088000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q4,2010-10-01,2010-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,6182000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q4,2010-10-01,2010-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,21000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:05:58+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,44545000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:05:58+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,44545000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:05:58+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,313000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:05:58+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2044000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:05:58+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-64950000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:05:58+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4896000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:05:58+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13152000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:05:58+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13152000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:05:58+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-48313000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:05:58+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17881000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:05:58+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-30432000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:05:58+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-30432000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:05:58+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-20311000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:05:58+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-20966000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:05:58+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-41277000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:05:58+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-41277000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:05:58+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-84861000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:05:58+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,8071000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:05:58+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,14000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,69986000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,69986000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,356000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2032000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,28223000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,478000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,101075000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,101075000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-50000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-10046000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8265000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1831000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1831000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-176723000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-20958000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,149643000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,10868000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-20765000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-57935000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-57935000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,41309000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,2011-04-01,2011-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,5715000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,2011-04-01,2011-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,14000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,45916000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,45916000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,363000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3266000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,129000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-12961000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,36713000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,36713000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,50000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-13338000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,13000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-288000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-288000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-26432000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-20952000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,69000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-10868000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,10868000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-47315000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-47315000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10890000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,2011-07-01,2011-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,6218000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,2011-07-01,2011-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,38000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,38942000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,38942000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,373000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-1956000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4784000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3003000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,45146000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,45146000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3047000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11550000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8503000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8503000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-21285000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-20952000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,10868000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-10868000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-42237000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-42237000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,11412000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q4,2011-10-01,2011-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,5623000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q4,2011-10-01,2011-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,17000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:03:06+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,40184000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:03:06+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,40184000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:03:06+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,298000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:03:06+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3668000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:03:06+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-27212000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:03:06+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,958000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:03:06+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,17896000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:03:06+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,17896000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:03:06+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:03:06+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5993000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:03:06+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:03:06+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-7425000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:03:06+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,574000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:03:06+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,574000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:03:06+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-24684000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:03:06+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-20962000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:03:06+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-45646000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:03:06+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-45646000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:03:06+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-27176000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:03:06+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,4980000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:03:06+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,18000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,73502000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,73502000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,288000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3553000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,141000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,27413000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,104897000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,104897000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-11000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5989000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5989000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-46793000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-20962000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,7000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-67748000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-67748000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,43138000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,2012-04-01,2012-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,4693000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,2012-04-01,2012-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,12000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,48575000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,48575000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,218000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3286000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-126000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-16124000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,35829000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,35829000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,1000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-19999000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,16799000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-40839000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-44038000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-44038000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-22738000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-20962000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-7000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-43707000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-43707000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-51916000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,2012-07-01,2012-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,3170000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,2012-07-01,2012-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,46000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,49408000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,49408000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2186000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,51594000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,51594000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-33000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3906000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,19032000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-47036000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-31943000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-31943000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-21056000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,27000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-21029000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-21029000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1378000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q4,2012-10-01,2012-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2911000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q4,2012-10-01,2012-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,23000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:04:14+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,53471000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:04:14+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,53471000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:04:14+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,50000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:04:14+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3251000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:04:14+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,153000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:04:14+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4070000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:04:14+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,52855000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:04:14+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,52855000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:04:14+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,21684000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:04:14+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2579000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:04:14+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,19105000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:04:14+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,19105000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:04:14+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:04:14+00:00,netcashfromcontinuingfinancingactivities,repurchaseofpreferredequity,Repurchase of Preferred Equity,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:04:14+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-20980000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:04:14+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:04:14+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:04:14+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:04:14+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-20980000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:04:14+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-20980000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:04:14+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,50980000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:04:14+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,2588000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:04:14+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,28000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,93742000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,93742000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,-264000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3301000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,215000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,12860000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,109854000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,109854000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-6375000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11500000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-24725000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-19602000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-19602000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-20984000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,13000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-20971000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-20971000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,69281000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,2013-04-01,2013-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2910000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,2013-04-01,2013-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,27000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,56225000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,56225000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,-146000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3369000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,182000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-13804000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,45826000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,45826000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3500000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,68193000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-21404000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,43289000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,43289000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-20979000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-13000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-20992000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-20992000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,68123000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,2013-07-01,2013-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2588000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,2013-07-01,2013-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,46000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,61092000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,61092000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,-44000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,9036000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,300000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8018000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,62366000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,62355000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-241314000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,537000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-100000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-340777000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-340777000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-21063000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,74169000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,22000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,53128000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,53128000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-225294000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q4,2013-10-01,2013-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2911000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q4,2013-10-01,2013-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,38000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:02:08+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,72883000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:02:08+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,72883000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:02:08+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,-45000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:02:08+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,4817000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:02:08+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-5372000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:02:08+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4142000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:02:08+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,68141000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:02:08+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,68141000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:02:08+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,23638000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:02:08+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:02:08+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-50000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:02:08+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-26362000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:02:08+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-26362000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:02:08+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-28574000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:02:08+00:00,netcashfromcontinuingfinancingactivities,repurchaseofpreferredequity,Repurchase of Preferred Equity,+,debit,usd,-29906000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:02:08+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-24042000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:02:08+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,300000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:02:08+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,11427000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:02:08+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-30951000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:02:08+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,197954000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:02:08+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,197954000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:02:08+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,239733000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:02:08+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,5454000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:02:08+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,34000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,92055000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,92055000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,-49000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,4751000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-33262000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,14517000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,78012000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,78012000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-39000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,25813000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-180500000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-154726000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-154726000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-18750000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-24046000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-42796000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-42796000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-119510000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,2014-04-01,2014-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,3222000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,2014-04-01,2014-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,47000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:10:16+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,84498000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:10:16+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,84498000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:10:16+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,10000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:10:16+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,4066000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:10:16+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-10861000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:10:16+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5867000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:10:16+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,71846000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:10:16+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,71846000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:10:16+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,938000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:10:16+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:10:16+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:10:16+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,938000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:10:16+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,938000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:10:16+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-607000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:10:16+00:00,netcashfromcontinuingfinancingactivities,repurchaseofpreferredequity,Repurchase of Preferred Equity,+,debit,usd,-22337000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:10:16+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-24549000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:10:16+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,100000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:10:16+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,52507000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:10:16+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,52507000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:10:16+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,125291000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:10:16+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,6332000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:10:16+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,52000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,78264000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,78264000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,10000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3144000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-11990000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,14626000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,84054000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,84054000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,1153000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-5226000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4073000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4073000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-25000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofpreferredequity,Repurchase of Preferred Equity,+,debit,usd,-155050000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-24534000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-204584000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-204584000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-124603000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,2015-04-01,2015-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,3323000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,2015-04-01,2015-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,32000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,69459000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,69459000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,9000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2534000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4321000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-837000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,75486000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,75486000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,6879000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,21724000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-118750000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-90156000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-90156000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-25000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-24540000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-49540000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-49540000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-64210000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,2015-07-01,2015-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,6390000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,2015-07-01,2015-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,41000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,100574000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,100574000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,11000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3219000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-51260000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,17535000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,70079000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,70079000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,59679000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,-19777000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-26259000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,13643000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,13643000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-25000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofpreferredequity,Repurchase of Preferred Equity,+,debit,usd,-43010000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-24684000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-92694000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-92694000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8972000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,942000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q4,2015-10-01,2015-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,43000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:23:00+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,55887000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:23:00+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,55887000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:23:00+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,9000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:23:00+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2461000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:23:00+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,27752000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:23:00+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,6397000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:23:00+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,92506000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:23:00+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,92506000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:23:00+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:23:00+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:23:00+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,17221000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:23:00+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,273000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:23:00+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-5000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:23:00+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,12494000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:23:00+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,12494000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:23:00+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-25000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:23:00+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:23:00+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-8233000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:23:00+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-33233000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:23:00+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-33233000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:23:00+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,71767000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:23:00+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,5001000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:23:00+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,22000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4148000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4148000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1558000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,923000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4387000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2246000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2246000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-75000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,14688000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1408000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-109938000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-168842000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-168842000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-8200000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-8200000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-8200000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-174796000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,2016-04-01,2016-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,12000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,13904000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13904000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,8062000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-15035000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-15621000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8687000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8687000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-7985000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,15331000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,54652000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-62500000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-502000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-502000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-325000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,250000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-75000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-75000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9264000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,2016-07-01,2016-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,4929000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,2016-07-01,2016-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,16000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10280000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10280000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,9956000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,30529000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-14554000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,15653000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,15653000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-25000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-14967000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,79995000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,-51653000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1010000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,12340000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,12340000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2879000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofpreferredequity,Repurchase of Preferred Equity,+,debit,usd,-120000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-150000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,150000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-14400000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,12571000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,12571000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,40564000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q4,2016-10-01,2016-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1480000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:23:00+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,7194000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:23:00+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7194000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:23:00+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,66000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:23:00+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,8690000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:23:00+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-11966000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:23:00+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,41798000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:23:00+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,45782000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:23:00+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,45782000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:23:00+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-534000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:23:00+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-15975000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:23:00+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,121663000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:23:00+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,23905000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:23:00+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:23:00+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,129059000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:23:00+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,129059000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:23:00+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:23:00+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-7647000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:23:00+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-21000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:23:00+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-7668000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:23:00+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-7668000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:23:00+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,167173000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:23:00+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,2529000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:23:00+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,120000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,60439000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,60439000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,525000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,8868000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-82708000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,28706000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,15830000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,15830000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-171000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3885000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,34568000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,13282000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,43794000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,43794000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-22353000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-2170000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-24523000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-24523000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,35101000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,2017-04-01,2017-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2166000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,2017-04-01,2017-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,14085000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,20732000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,20732000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,887000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,9075000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-38587000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4344000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3549000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3549000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-455000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3353000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,171171000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,83850000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,251213000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,251213000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-87007000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-87007000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-87007000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,160657000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,2017-07-01,2017-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2529000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,2017-07-01,2017-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,20915000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,22336000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,22336000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,888000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,9094000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-35345000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-14412000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17439000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17439000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-137000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,32849000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2109000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,34821000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,34821000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,87007000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-201000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-87007000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-201000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-201000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,17181000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2062000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q4,2017-10-01,2017-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,8246000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:07:03+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1602000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:07:03+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1602000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:07:03+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1004000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:07:03+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,8425000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:07:03+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-10796000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:07:03+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-13756000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:07:03+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13521000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:07:03+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13521000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:07:03+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1398000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:07:03+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:07:03+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,18623000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:07:03+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4115000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:07:03+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:07:03+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,21340000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:07:03+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,21340000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:07:03+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-126447000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:07:03+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-3560000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:07:03+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:07:03+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:07:03+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-130007000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:07:03+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-130007000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:07:03+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-122188000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:07:03+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,2529000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:07:03+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,644000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-112296000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-112296000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1024000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,8163000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,140756000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-43882000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6235000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6235000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2517000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,19370000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,16854000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,16854000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-20044000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-20044000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-20044000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9425000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,2018-04-01,2018-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2062000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,2018-04-01,2018-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3336000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,25556000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,25556000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1033000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3411000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-39631000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,18028000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,8397000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,8397000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-726000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,19056000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-20000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1670000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1670000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1396000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1396000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1396000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5331000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,2018-07-01,2018-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,39000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,16279000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,16279000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,635000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3441000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-10995000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-11426000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2066000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2066000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,118000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,20920000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-858000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,20180000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,20180000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-24109000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-48000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-351000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-24508000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-24508000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6394000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q4,2018-10-01,2018-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2063000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q4,2018-10-01,2018-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-214000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 21:32:36+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,6617000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 21:32:36+00:00,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,15069000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 21:32:36+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8452000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 21:32:36+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,827000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 21:32:36+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2394000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 21:32:36+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1115000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 21:32:36+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1813000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 21:32:36+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2303000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 21:32:36+00:00,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,6818000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 21:32:36+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4515000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 21:32:36+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-42000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 21:32:36+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-42000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 21:32:36+00:00,netcashfrominvestingactivities,netcashfromdiscontinuedinvestingactivities,Net Cash From Discontinued Investing Activities,+,debit,usd,12620000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 21:32:36+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,12578000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 21:32:36+00:00,netcashfromcontinuingfinancingactivities,repurchaseofpreferredequity,Repurchase of Preferred Equity,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 21:32:36+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-44288000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 21:32:36+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1071000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 21:32:36+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-45359000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 21:32:36+00:00,netcashfromfinancingactivities,netcashfromdiscontinuedfinancingactivities,Net Cash From Discontinued Financing Activities,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 21:32:36+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-45359000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 21:32:36+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-28266000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 21:32:36+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 21:32:36+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-2773000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4514000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,-15069000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10555000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,822000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,5093000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-7543000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-14799000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5872000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,-6818000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12690000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-121000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1700000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-60000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,32726000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-29095000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromdiscontinuedinvestingactivities,Net Cash From Discontinued Investing Activities,+,debit,usd,-12620000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-41715000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-26978000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-26978000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-26978000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-81383000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,2019-04-01,2019-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2063000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,2019-04-01,2019-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,80000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17966000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17966000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,646000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3696000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,14000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,8486000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5124000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5124000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-341000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,25564000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,30223000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,30223000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-7451000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-4625000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-3694000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-15770000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-15770000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,9329000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,2019-07-01,2019-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,8000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-54828000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-54828000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,606000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3246000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,52425000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-20593000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19144000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19144000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-259000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,20982000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,5000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,-5000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,20723000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,20723000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofpreferredequity,Repurchase of Preferred Equity,+,debit,usd,-97889000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-11007000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-9000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,6507000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-102398000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-102398000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-100819000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q4,2019-10-01,2019-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2202000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q4,2019-10-01,2019-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-4000.0
